Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 38

1.

Proteomic study of the membrane components of signalling cascades of Botrytis cinerea controlled by phosphorylation.

Escobar-Niño A, Liñeiro E, Amil F, Carrasco R, Chiva C, Fuentes C, Blanco-Ulate B, Cantoral Fernández JM, Sabidó E, Fernández-Acero FJ.

Sci Rep. 2019 Jul 8;9(1):9860. doi: 10.1038/s41598-019-46270-0.

2.

Molecular basis for the protective effects of low-density lipoprotein receptor-related protein 1 (LRP1)-derived peptides against LDL aggregation.

Benitez-Amaro A, Pallara C, Nasarre L, Rivas-Urbina A, Benitez S, Vea A, Bornachea O, de Gonzalo-Calvo D, Serra-Mir G, Villegas S, Prades R, Sanchez-Quesada JL, Chiva C, Sabido E, Tarragó T, Llorente-Cortés V.

Biochim Biophys Acta Biomembr. 2019 Jul 1;1861(7):1302-1316. doi: 10.1016/j.bbamem.2019.05.003. Epub 2019 May 8.

PMID:
31077676
3.

Isotopologue Multipoint Calibration for Proteomics Biomarker Quantification in Clinical Practice.

Chiva C, Pastor O, Trilla-Fuertes L, Gámez-Pozo A, Fresno Vara JÁ, Sabidó E.

Anal Chem. 2019 Apr 16;91(8):4934-4938. doi: 10.1021/acs.analchem.8b05802. Epub 2019 Mar 25.

PMID:
30882204
4.

Proteomics characterisation of central nervous system metastasis biomarkers in triple negative breast cancer.

Rojas L K, Trilla-Fuertes L, Gámez-Pozo A, Chiva C, Sepúlveda J, Manso L, Prado-Vázquez G, Zapater-Moros A, López-Vacas R, Ferrer-Gómez M, Mendiola C, Espinosa E, Sabidó E, Ciruelos E, Vara JÁF.

Ecancermedicalscience. 2019 Jan 15;13:891. doi: 10.3332/ecancer.2019.891. eCollection 2019.

5.

Changes in Synaptic Proteins Precede Neurodegeneration Markers in Preclinical Alzheimer's Disease Cerebrospinal Fluid.

Lleó A, Núñez-Llaves R, Alcolea D, Chiva C, Balateu-Paños D, Colom-Cadena M, Gomez-Giro G, Muñoz L, Querol-Vilaseca M, Pegueroles J, Rami L, Lladó A, Molinuevo JL, Tainta M, Clarimón J, Spires-Jones T, Blesa R, Fortea J, Martínez-Lage P, Sánchez-Valle R, Sabidó E, Bayés À, Belbin O.

Mol Cell Proteomics. 2019 Mar;18(3):546-560. doi: 10.1074/mcp.RA118.001290. Epub 2019 Jan 3.

PMID:
30606734
6.

QCloud: A cloud-based quality control system for mass spectrometry-based proteomics laboratories.

Chiva C, Olivella R, Borràs E, Espadas G, Pastor O, Solé A, Sabidó E.

PLoS One. 2018 Jan 11;13(1):e0189209. doi: 10.1371/journal.pone.0189209. eCollection 2018.

7.

Prediction of adjuvant chemotherapy response in triple negative breast cancer with discovery and targeted proteomics.

Gámez-Pozo A, Trilla-Fuertes L, Prado-Vázquez G, Chiva C, López-Vacas R, Nanni P, Berges-Soria J, Grossmann J, Díaz-Almirón M, Ciruelos E, Sabidó E, Espinosa E, Fresno Vara JÁ.

PLoS One. 2017 Jun 8;12(6):e0178296. doi: 10.1371/journal.pone.0178296. eCollection 2017.

8.
9.

Peptide Selection for Targeted Protein Quantitation.

Chiva C, Sabidó E.

J Proteome Res. 2017 Mar 3;16(3):1376-1380. doi: 10.1021/acs.jproteome.6b00115. Epub 2017 Jan 30.

PMID:
28102078
10.

Targeted proteomics in urinary extracellular vesicles identifies biomarkers for diagnosis and prognosis of prostate cancer.

Sequeiros T, Rigau M, Chiva C, Montes M, Garcia-Grau I, Garcia M, Diaz S, Celma A, Bijnsdorp I, Campos A, Di Mauro P, Borrós S, Reventós J, Doll A, Paciucci R, Pegtel M, de Torres I, Sabidó E, Morote J, Olivan M.

Oncotarget. 2017 Jan 17;8(3):4960-4976. doi: 10.18632/oncotarget.13634.

11.

Dataset of the Botrytis cinerea phosphoproteome induced by different plant-based elicitors.

Liñeiro E, Chiva C, Cantoral JM, Sabido E, Fernández-Acero FJ.

Data Brief. 2016 Apr 22;7:1447-1450. eCollection 2016 Jun.

12.

Modifications of fungal membrane proteins profile under pathogenicity induction: A proteomic analysis of Botrytis cinerea membranome.

Liñeiro E, Chiva C, Cantoral JM, Sabidó E, Fernández-Acero FJ.

Proteomics. 2016 Sep;16(17):2363-76. doi: 10.1002/pmic.201500496. Epub 2016 Aug 5.

PMID:
27329576
13.

The Dynamic Regulatory Genome of Capsaspora and the Origin of Animal Multicellularity.

Sebé-Pedrós A, Ballaré C, Parra-Acero H, Chiva C, Tena JJ, Sabidó E, Gómez-Skarmeta JL, Di Croce L, Ruiz-Trillo I.

Cell. 2016 May 19;165(5):1224-1237. doi: 10.1016/j.cell.2016.03.034. Epub 2016 Apr 21.

14.

Phosphoproteome analysis of B. cinerea in response to different plant-based elicitors.

Liñeiro E, Chiva C, Cantoral JM, Sabido E, Fernández-Acero FJ.

J Proteomics. 2016 Apr 29;139:84-94. doi: 10.1016/j.jprot.2016.03.019. Epub 2016 Mar 18.

PMID:
27003611
15.

Origins of De Novo Genes in Human and Chimpanzee.

Ruiz-Orera J, Hernandez-Rodriguez J, Chiva C, Sabidó E, Kondova I, Bontrop R, Marqués-Bonet T, Albà MM.

PLoS Genet. 2015 Dec 31;11(12):e1005721. doi: 10.1371/journal.pgen.1005721. eCollection 2015 Dec.

16.

Protein-Based Classifier to Predict Conversion from Clinically Isolated Syndrome to Multiple Sclerosis.

Borràs E, Cantó E, Choi M, Maria Villar L, Álvarez-Cermeño JC, Chiva C, Montalban X, Vitek O, Comabella M, Sabidó E.

Mol Cell Proteomics. 2016 Jan;15(1):318-28. doi: 10.1074/mcp.M115.053256. Epub 2015 Nov 9.

17.

Multicenter experiment for quality control of peptide-centric LC-MS/MS analysis - A longitudinal performance assessment with nLC coupled to orbitrap MS analyzers.

Campos A, Díaz R, Martínez-Bartolomé S, Sierra J, Gallardo O, Sabidó E, López-Lucendo M, Ignacio Casal J, Pasquarello C, Scherl A, Chiva C, Borras E, Odena A, Elortza F, Azkargorta M, Ibarrola N, Canals F, Albar JP, Oliveira E.

J Proteomics. 2015 Sep 8;127(Pt B):264-74. doi: 10.1016/j.jprot.2015.05.012. Epub 2015 May 14.

PMID:
25982386
18.

Validation of semaphorin 7A and ala-β-his-dipeptidase as biomarkers associated with the conversion from clinically isolated syndrome to multiple sclerosis.

Cantó E, Tintoré M, Villar LM, Borrás E, Alvarez-Cermeño JC, Chiva C, Sabidó E, Rovira A, Montalban X, Comabella M.

J Neuroinflammation. 2014 Nov 13;11:181. doi: 10.1186/s12974-014-0181-8.

19.

Identification of N-terminal protein acetylation and arginine methylation of the voltage-gated sodium channel in end-stage heart failure human heart.

Beltran-Alvarez P, Tarradas A, Chiva C, Pérez-Serra A, Batlle M, Pérez-Villa F, Schulte U, Sabidó E, Brugada R, Pagans S.

J Mol Cell Cardiol. 2014 Nov;76:126-9. doi: 10.1016/j.yjmcc.2014.08.014. Epub 2014 Aug 27.

PMID:
25172307
20.

Influence of the digestion technique, protease, and missed cleavage peptides in protein quantitation.

Chiva C, Ortega M, Sabidó E.

J Proteome Res. 2014 Sep 5;13(9):3979-86. doi: 10.1021/pr500294d. Epub 2014 Jul 28.

PMID:
24986539
21.

Profiling the secretome and extracellular proteome of the potato late blight pathogen Phytophthora infestans.

Meijer HJ, Mancuso FM, Espadas G, Seidl MF, Chiva C, Govers F, Sabidó E.

Mol Cell Proteomics. 2014 Aug;13(8):2101-13. doi: 10.1074/mcp.M113.035873. Epub 2014 May 28.

22.

HCD-only fragmentation method balances peptide identification and quantitation of TMT-labeled samples in hybrid linear ion trap/orbitrap mass spectrometers.

Chiva C, Sabidó E.

J Proteomics. 2014 Jan 16;96:263-70. doi: 10.1016/j.jprot.2013.11.013. Epub 2013 Nov 23.

PMID:
24275568
23.

Integrative quantitation enables a comprehensive proteome comparison of two Mycoplasma pneumoniae genetic perturbations.

Borràs E, Espadas G, Mancuso FM, Maier T, Chiva C, Sabidó E.

Mol Biosyst. 2013 Jun;9(6):1249-56. doi: 10.1039/c3mb25581f. Epub 2013 Apr 12.

PMID:
23579234
24.

Alterations of the erythrocyte membrane proteome and cytoskeleton network during storage--a possible tool to identify autologous blood transfusion.

Nikolovski Z, De La Torre C, Chiva C, Borràs E, Andreu D, Ventura R, Segura J.

Drug Test Anal. 2012 Nov;4(11):882-90. doi: 10.1002/dta.1342. Epub 2012 Apr 29.

PMID:
22544525
25.

Cerebrospinal fluid chitinase 3-like 1 levels are associated with conversion to multiple sclerosis.

Comabella M, Fernández M, Martin R, Rivera-Vallvé S, Borrás E, Chiva C, Julià E, Rovira A, Cantó E, Alvarez-Cermeño JC, Villar LM, Tintoré M, Montalban X.

Brain. 2010 Apr;133(Pt 4):1082-93. doi: 10.1093/brain/awq035. Epub 2010 Mar 17.

PMID:
20237129
26.

The cost of resistance to colistin in Acinetobacter baumannii: a proteomic perspective.

Fernández-Reyes M, Rodríguez-Falcón M, Chiva C, Pachón J, Andreu D, Rivas L.

Proteomics. 2009 Mar;9(6):1632-45. doi: 10.1002/pmic.200800434.

PMID:
19253303
27.

Identification of a tachykinin-related peptide with orexigenic properties in the German cockroach.

Pascual N, Maestro JL, Chiva C, Andreu D, Bellés X.

Peptides. 2008 Mar;29(3):386-92. doi: 10.1016/j.peptides.2007.11.010. Epub 2007 Nov 22.

PMID:
18178289
28.

A proteomic approach to the identification of new tPA receptors in pancreatic cancer cells.

Roda O, Chiva C, Espuña G, Gabius HJ, Real FX, Navarro P, Andreu D.

Proteomics. 2006 Apr;6 Suppl 1:S36-41. Review.

PMID:
16544279
29.

Bcl-x(L)-mediated changes in metabolic pathways of breast cancer cells: from survival in the blood stream to organ-specific metastasis.

España L, Martín B, Aragüés R, Chiva C, Oliva B, Andreu D, Sierra A.

Am J Pathol. 2005 Oct;167(4):1125-37.

30.

Immunogenicity and T cell recognition in swine of foot-and-mouth disease virus polymerase 3D.

García-Briones MM, Blanco E, Chiva C, Andreu D, Ley V, Sobrino F.

Virology. 2004 May 1;322(2):264-75.

31.

Identification of leucomyosuppressin in the German cockroach, Blattella germanica, as an inhibitor of food intake.

Aguilar R, Maestro JL, Vilaplana L, Chiva C, Andreu D, Bellés X.

Regul Pept. 2004 Jun 15;119(1-2):105-12.

PMID:
15093704
32.

Identification of new leishmanicidal peptide lead structures by automated real-time monitoring of changes in intracellular ATP.

Luque-Ortega JR, Saugar JM, Chiva C, Andreu D, Rivas L.

Biochem J. 2003 Oct 1;375(Pt 1):221-30.

33.

Synthesis and NMR structure of p41icf, a potent inhibitor of human cathepsin L.

Chiva C, Barthe P, Codina A, Gairí M, Molina F, Granier C, Pugnière M, Inui T, Nishio H, Nishiuchi Y, Kimura T, Sakakibara S, Albericio F, Giralt E.

J Am Chem Soc. 2003 Feb 12;125(6):1508-17.

PMID:
12568610
34.

Diethylmaleate activates the transcription factor Pap1 by covalent modification of critical cysteine residues.

Castillo EA, Ayté J, Chiva C, Moldón A, Carrascal M, Abián J, Jones N, Hidalgo E.

Mol Microbiol. 2002 Jul;45(1):243-54.

35.

Effects of L- and D-REKR amino acid-containing peptides on HIV and SIV envelope glycoprotein precursor maturation and HIV and SIV replication.

Bahbouhi B, Chazal N, Seidah NG, Chiva C, Kogan M, Albericio F, Giralt E, Bahraoui E.

Biochem J. 2002 Sep 15;366(Pt 3):863-72.

36.

Inhibition of HIV-2(ROD) replication in a lymphoblastoid cell line by the alpha1-antitrypsin Portland variant (alpha1-PDX) and the decRVKRcmk peptide: comparison with HIV-1(LAI).

Bahbouhi B, Bendjennat M, Chiva C, Kogan M, Albericio F, Giralt E, Seidah NG, Bahraoui E.

Microbes Infect. 2001 Nov;3(13):1073-84.

PMID:
11709287
37.

Interspecies major histocompatibility complex-restricted Th cell epitope on foot-and-mouth disease virus capsid protein VP4.

Blanco E, McCullough K, Summerfield A, Fiorini J, Andreu D, Chiva C, Borrás E, Barnett P, Sobrino F.

J Virol. 2000 May;74(10):4902-7.

38.

An HPLC-ESMS study on the solid-phase assembly of C-terminal proline peptides.

Chiva C, Vilaseca M, Giralt E, Albericio F.

J Pept Sci. 1999 Mar;5(3):131-40.

PMID:
10323557

Supplemental Content

Support Center